NMS Labs Promotes Shelly H. Carolan to CMO and James G. Murphy to CFO--Two New Posts on its Executive Leadership Team

WILLOW GROVE, Pa.--()--NMS Labs, a premier independent provider of professional forensic and clinical laboratory services, has announced the promotion of two key individuals on its executive leadership team. Shelly H. Carolan, MBA, who joined NMS Labs in August 2005 as Vice President of Sales & Marketing, has been promoted to the newly created post of Chief Marketing Officer (CMO). In addition, James G. Murphy, who joined NMS Labs in March 2008 as Vice President of Finance, has been promoted to Chief Financial Officer (CFO).

Regarding the appointments, Dr. Eric Rieders, President and CEO of NMS Labs, said, "As we face ambitious goals, our board felt that it was important to expand the executive team to include both CFO and CMO positions. We are confident that Jim and Shelly have the competence, drive, and vision that we are seeking to bring our company into a bright future that is rooted in the values of our past successes."

In her new position, Ms. Carolan will be responsible for facilitating revenue growth through key sales and marketing strategies, including market and product expansion, while ensuring customer retention and customer service levels. She also serves on the Board of Directors of the Fredric Rieders Family Renaissance Foundation. Prior to joining NMS Labs, Ms. Carolan was Senior Vice President for the Lab Support division of On Assignment. She has extensive sales and marketing experience at scientific-based organizations, earned an Executive MBA from Pepperdine University, and has a BS from Boston University.

As CFO, Mr. Murphy continues to supervise the financial and various administrative departments for NMS Labs. Mr. Murphy, who has more than 25 years of senior financial management experience, specializes in the communications and healthcare industries. While serving as CFO of three publicly held companies, he raised more than $1 billion in capital. Mr. Murphy is also a member of the Board of Directors of a BioMimetic Therapeutics, Inc., a publicly held medical device company. He is a graduate of Villanova University and is a Certified Public Accountant.

About NMS Labs:

NMS Labs is a national reference laboratory that is unsurpassed in its scope of toxicology tests, accuracy of results, scientific expertise, and innovation. NMS Labs is passionate about promoting public health and safety. For more information on NMS Labs, please visit www.nmslabs.com.

Contacts

NMS Labs
Pam Lipschutz, Marketing, 215-366-1638

Release Summary

Shelly Carolan and Jim Murphy promoted to newly expanded executive team at NMS Labs

Contacts

NMS Labs
Pam Lipschutz, Marketing, 215-366-1638